These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23178639)

  • 1. Estimating a preference-based index from the Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM): valuation of CORE-6D.
    Mavranezouli I; Brazier JE; Rowen D; Barkham M
    Med Decis Making; 2013 Apr; 33(3):381-95. PubMed ID: 23178639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Rasch analysis to form plausible health states amenable to valuation: the development of CORE-6D from a measure of common mental health problems (CORE-OM).
    Mavranezouli I; Brazier JE; Young TA; Barkham M
    Qual Life Res; 2011 Apr; 20(3):321-33. PubMed ID: 20972629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome).
    Brazier JE; Rowen D; Mavranezouli I; Tsuchiya A; Young T; Yang Y; Barkham M; Ibbotson R
    Health Technol Assess; 2012 Jul; 16(32):1-114. PubMed ID: 22832015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the SF-6D value set for a population-based sample of Brazilians.
    Cruz LN; Camey SA; Hoffmann JF; Rowen D; Brazier JE; Fleck MP; Polanczyk CA
    Value Health; 2011; 14(5 Suppl 1):S108-14. PubMed ID: 21839880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring quality of life for people with common mental health problems.
    Wickramasekera N; Tubeuf S
    J Ment Health; 2023 Feb; 32(1):3-10. PubMed ID: 32915686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.
    Richardson SS; Berven S
    Spine J; 2012 Jan; 12(1):55-62. PubMed ID: 22209244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing preference-based health measures: using Rasch analysis to generate health state values.
    Young TA; Rowen D; Norquist J; Brazier JE
    Qual Life Res; 2010 Aug; 19(6):907-17. PubMed ID: 20454864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preference-based measure of health: the VR-6D derived from the veterans RAND 12-Item Health Survey.
    Selim AJ; Rogers W; Qian SX; Brazier J; Kazis LE
    Qual Life Res; 2011 Oct; 20(8):1337-47. PubMed ID: 21336657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the Feasibility and Acceptability of Valuing the Arabic Version of SF-6D in a Lebanese Population.
    Kharroubi SA; Beyh Y; Harake MDE; Dawoud D; Rowen D; Brazier J
    Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32041284
    [No Abstract]   [Full Text] [Related]  

  • 10. Developing a New Version of the SF-6D Health State Classification System From the SF-36v2: SF-6Dv2.
    Brazier JE; Mulhern BJ; Bjorner JB; Gandek B; Rowen D; Alonso J; Vilagut G; Ware JE;
    Med Care; 2020 Jun; 58(6):557-565. PubMed ID: 32412942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating a preference-based single index for the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) instrument from the SF-6D.
    Brazier JE; Kolotkin RL; Crosby RD; Williams GR
    Value Health; 2004; 7(4):490-8. PubMed ID: 15449641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Bayesian methods to model the SF-6D health state preference based data.
    Kharroubi SA
    Health Qual Life Outcomes; 2018 Dec; 16(1):234. PubMed ID: 30563528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets.
    Tsuchiya A; Brazier J; Roberts J
    J Health Econ; 2006 Mar; 25(2):334-46. PubMed ID: 16271783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating a Preference-Based Index for Mental Health From the Recovering Quality of Life Measure: Valuation of Recovering Quality of Life Utility Index.
    Keetharuth AD; Rowen D; Bjorner JB; Brazier J
    Value Health; 2021 Feb; 24(2):281-290. PubMed ID: 33518035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.
    Whitehurst DG; Norman R; Brazier JE; Viney R
    Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient and public preferences for health states associated with AMD.
    Butt T; Dunbar HM; Morris S; Orr S; Rubin GS
    Optom Vis Sci; 2013 Aug; 90(8):855-60. PubMed ID: 23811607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CORE-OM as a routine outcome measure for adolescents with emotional disorders: factor structure and psychometric properties.
    Lorentzen V; HandegÄrd BH; Moen CM; Solem K; Lillevoll K; Skre I
    BMC Psychol; 2020 Aug; 8(1):86. PubMed ID: 32819424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unchained melody: revisiting the estimation of SF-6D values.
    Craig BM
    Eur J Health Econ; 2016 Sep; 17(7):865-73. PubMed ID: 26359242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of Hong Kong and United Kingdom SF-6D health states valuations using a nonparametric Bayesian method.
    Kharroubi SA; Brazier JE; McGhee S
    Value Health; 2014 Jun; 17(4):397-405. PubMed ID: 24969000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the relationship between the EQ-5D, SF-6D, HAQ and disease activity in inflammatory arthritis.
    Adams R; Walsh C; Veale D; Bresnihan B; FitzGerald O; Barry M
    Pharmacoeconomics; 2010; 28(6):477-87. PubMed ID: 20465316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.